Position
Renaissance Technologies in Maxcyte, Inc.
Back to the book · All holders of MXCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.01M$0.70 → $1.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 786.9K | $1.22M | — | — | — | 0.0% |
| Q1 2026 | 1.99M | $1.4M | $0.70 | −$666.9K | $847.4K | 0.0% |
| Q2 2026 | 1.91M | $2.35M | $1.23 | $1.01M | −$57.9K | 0.0% |